Oralyn has been reformulated. It's a much better product. It can now compete with subcu insulin, when it never could before. Needs funding to advance the project. Definitely in our diabetic plans.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
